Arcadia Biosciences (RKDA) Non-Current Debt (2014 - 2021)

Arcadia Biosciences has reported Non-Current Debt for 7 years, with the latest figure at $78000.0 in Q3 2021.

• For the quarter ending Q3 2021, Non-Current Debt fell 96.94% year-over-year to $78000.0; the trailing twelve-month figure through Sep 2021 stood at $78000.0 (down 96.94% YoY), and the FY2020 full-year result was $2.1 million, up 1867.29% from the prior year.
• Non-Current Debt for Q3 2021 stood at $78000.0, down from $87000.0 in the prior quarter.
• The five-year high for Non-Current Debt was $23.1 million in Q1 2017, with the low at $78000.0 in Q3 2021.
• Historically, Non-Current Debt has averaged $4.7 million across 4 years, with a median of $130000.0 in 2020.
• Annual changes were most pronounced in 2020 — Non-Current Debt surged 2154.87% — and 2021, when it plunged 96.94%.
• Arcadia Biosciences' Non-Current Debt stood at $21.1 million in 2017, then plunged by 99.49% to $107000.0 in 2019, then surged by 1867.29% to $2.1 million in 2020, then plunged by 96.29% to $78000.0 in 2021.
• The last three Non-Current Debt figures came in at $78000.0 (Q3 2021), $87000.0 (Q2 2021), and $96000.0 (Q1 2021), per Business Quant data.